.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Oral insulin absorption remains one of the most significant hurdles in diabetes management today. Despite years of dedicated research, researchers still struggle to deliver proteins effectively through the gastrointestinal tract. A recent study introduces a natural metabolite-based deep eutectic system (BL-DES) to overcome these physical barriers. This food-grade strategy uses a combination of betaine and lactic acid to enhance the movement of proteins. By addressing the specific challenges of the gut environment, this technology offers a promising path for future diabetic care.
The BL-DES system works through multiple mechanisms to improve drug delivery. First, it significantly reduces the viscosity of simulated intestinal mucus. Consequently, insulin can permeate the mucus layer much more easily than traditional oral formulations. Furthermore, jejunal administration of this system showed a significant hypoglycemic effect in preclinical tests. This discovery is vital for medical practitioners in India. In our clinical landscape, patient compliance with injectable insulin often limits the success of long-term treatment.
Beyond mucus penetration, the study highlights how BL-DES affects the intestinal epithelium directly. Mechanistic investigations show that the system promotes paracellular transport. It achieves this effect by reversibly opening tight junctions between intestinal cells. Because the process is reversible, the intestinal barrier remains intact and healthy after absorption is complete. Moreover, comprehensive hematological and histological evaluations confirmed that the system is safe and biocompatible. Therefore, this food-grade approach could soon revolutionize how we deliver various biologic medications.
BL-DES is a deep eutectic system made of betaine and lactic acid. It acts as a food-grade carrier to help proteins like insulin bypass intestinal barriers for better absorption.
The system reduces the thickness of intestinal mucus and safely opens the tight junctions between cells. This allowing insulin to enter the bloodstream without damaging the gut tissue.
Preliminary studies show high biocompatibility and safety in cellular and histological models. However, further clinical trials are necessary before it becomes available for human patients.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Di S et al. Enhanced Intestinal Absorption of Proteins via a Natural Metabolite-Based Deep Eutectic System. J Agric Food Chem. 2026 Apr 21. doi: 10.1021/acs.jafc.5c13281. PMID: 42012221.
Han et al. Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future directions. PMC. 2023.
Li et al. Deep Eutectic Solvents as Active Pharmaceutical Ingredient Delivery Systems in the Treatment of Metabolic Related Diseases. PMC. 2021.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have developed a betaine and lactic acid-based system (BL-DES) that significantly improves the intestinal absorption of proteins like insulin....
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
